Brief: Seres Therapeutics Q1 EPS USD -0.57
09/05/2023 13:46
May 9 (Reuters) - Seres Therapeutics Q1 operating expenses USD 70.046 million. * Q1 EPS USD -0.57 * Q1 operating income USD -70.568 million * Q1 net income USD -71.174 million
Recent news on Seres Therapeutics
See all newsChinese automakers make tech-led pitch for Europe's premium car market
Brief: Seres Therapeutics - May Offer Up To $300 Million Of Securities
Seres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Seres Therapeutics Q2 net income turns positive on VOWST sale gain
Brief: Seres Therapeutics Q2 EPS USD 0.47